A detailed history of Simplex Trading, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,339 shares of AADI stock, worth $7,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,339
Previous 2,484 5.84%
Holding current value
$7,017
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.32 - $2.06 $191 - $298
-145 Reduced 5.84%
2,339 $4,000
Q2 2024

Jul 25, 2024

BUY
$1.46 - $2.31 $1,508 - $2,386
1,033 Added 71.19%
2,484 $3,000
Q1 2024

Apr 25, 2024

SELL
$1.59 - $2.44 $5,103 - $7,832
-3,210 Reduced 68.87%
1,451 $3,000
Q4 2023

Feb 02, 2024

BUY
$1.97 - $5.41 $9,182 - $25,216
4,661 New
4,661 $9,000
Q1 2023

Apr 27, 2023

BUY
$6.85 - $13.0 $602 - $1,144
88 Added 733.33%
100 $0
Q4 2022

Feb 02, 2023

SELL
$11.99 - $14.5 $959 - $1,160
-80 Reduced 86.96%
12 $0
Q3 2022

Nov 04, 2022

BUY
$12.03 - $14.22 $1,106 - $1,308
92 New
92 $1,000
Q1 2022

May 02, 2022

SELL
$16.65 - $24.97 $1,664 - $2,497
-100 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$19.32 - $29.02 $1,932 - $2,902
100 New
100 $2,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $63.1M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.